X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (440) 440
Patent (117) 117
Publication (34) 34
Government Document (5) 5
Book Review (2) 2
Book Chapter (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (214) 214
oncology (163) 163
female (150) 150
chemistry (114) 114
metallurgy (112) 112
biochemistry (101) 101
beer (95) 95
enzymology (95) 95
index medicus (95) 95
microbiology (95) 95
mutation or genetic engineering (95) 95
spirits (95) 95
vinegar (95) 95
wine (95) 95
investigating or analysing materials by determining theirchemical or physical properties (86) 86
measuring (86) 86
physics (86) 86
testing (86) 86
breast cancer (81) 81
organic chemistry (80) 80
compositions or test papers therefor (75) 75
condition-responsive control in microbiological orenzymological processes (75) 75
measuring or testing processes involving enzymes, nucleicacids or microorganisms (75) 75
processes of preparing such compositions (75) 75
peptides (68) 68
human necessities (67) 67
hygiene (67) 67
medical or veterinary science (67) 67
preparations for medical, dental, or toilet purposes (67) 67
breast neoplasms - drug therapy (65) 65
middle aged (64) 64
breast neoplasms - genetics (63) 63
breast neoplasms - pathology (60) 60
cancer (59) 59
animals (58) 58
adult (52) 52
trastuzumab (50) 50
aged (48) 48
chemotherapy (46) 46
cell line, tumor (44) 44
expression (43) 43
gene amplification (43) 43
compositions thereof (38) 38
culture media (38) 38
microorganisms or enzymes (38) 38
propagating, preserving or maintaining microorganisms (38) 38
research (38) 38
breast neoplasms - metabolism (37) 37
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (37) 37
mice (36) 36
receptor, erbb-2 - genetics (35) 35
immunohistochemistry (33) 33
prognosis (33) 33
tumors (33) 33
antibodies, monoclonal, humanized (31) 31
genetic aspects (31) 31
antineoplastic combined chemotherapy protocols - therapeutic use (30) 30
biochemistry & molecular biology (30) 30
gene expression regulation, neoplastic (28) 28
ovarian-cancer (28) 28
gene expression (26) 26
identification (26) 26
male (26) 26
monoclonal-antibody (26) 26
survival (26) 26
article (25) 25
general tagging of cross-sectional technologies spanning over several sections of the ipc (25) 25
general tagging of new technological developments (25) 25
mutation (25) 25
processes using microorganisms (25) 25
receptor, erbb-2 - metabolism (25) 25
technical subjects covered by former uspc (25) 25
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (25) 25
antineoplastic agents - therapeutic use (24) 24
technical subjects covered by former uspc cross-reference artcollections [xracs] and digests (24) 24
treatment outcome (24) 24
tumor cells, cultured (24) 24
aged, 80 and over (23) 23
antibodies, monoclonal - therapeutic use (23) 23
cell biology (23) 23
disease-free survival (23) 23
genes (23) 23
therapy (23) 23
genetics & heredity (22) 22
in situ hybridization, fluorescence (22) 22
medical research (22) 22
oncogenes (22) 22
ovarian neoplasms - genetics (22) 22
care and treatment (21) 21
metastasis (21) 21
specific therapeutic activity of chemical compounds ormedicinal preparations (20) 20
amplification (19) 19
analysis (19) 19
breast neoplasms - mortality (19) 19
cells (19) 19
diagnosis (19) 19
carcinoma (18) 18
mice, nude (18) 18
ovarian cancer (18) 18
ovarian neoplasms - pathology (18) 18
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (551) 551
French (40) 40
German (20) 20
Danish (8) 8
Norwegian (4) 4
Finnish (3) 3
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Oncology Times, ISSN 0276-2234, 09/2008, Volume 30, Issue 17, pp. 3 - 3
Journal Article
by Garcia-Closas, Montserrat and Couch, Fergus J and Lindstrom, Sara and Michailidou, Kyriaki and Schmidt, Marjanka K and Brook, Mark N and Orr, Nick and Rhie, Suhn Kyong and Riboli, Elio and Feigelson, Heather S and Le Marchand, Loic and Buring, Julie E and Eccles, Diana and Miron, Penelope and Fasching, Peter A and Brauch, Hiltrud and Chang-Claude, Jenny and Carpenter, Jane and Godwin, Anew K and Nevanlinna, Heli and Giles, Graham G and Cox, Angela and Hopper, John L and Bolla, Manjeet K and Wang, Qin and Dennis, Joe and Dicks, Ed and Howat, Will J and Schoof, Nils and Bojesen, Stig E and Lambrechts, Diether and Broeks, Annegien and Anulis, Irene L and Guénel, Pascal and Burwinkel, Barbara and Sawyer, Elinor J and Hollestelle, Antoinette and Fletcher, Olivia and Winqvist, Robert and Brenner, Hermann and Mannermaa, Arto and Hamann, Ute and Meindl, Alfons and Lindblom, Annika and Zheng, Wei and Devillee, Peter and Goldberg, Mark S and Lubinski, Jan and Kristensen, Vessela and Swerdlow, Anthony and Anton-Culver, Hoda and Dörk, Thilo and Muir, Kenneth and Matsuo, Keitaro and Wu, Anna H and Radice, Paolo and teo, Soo Hwang and Shu, Xiao-Ou and Blot, William and Kang, Daehee and Hartman, Mikael and Sangrajrang, Suleeporn and Shen, Chen-Yang and Southey, Melissa C and Park, Daniel J and Hammet, Fleur and Stone, Jennifer and Veer, Laura J. Van't and Rutgers, Emiel J and Lophatananon, Artitaya and Stewart-Brown, Sarah and Siriwanarangsan, Pornthep and Peto, Julian and Schrauder, Michael G and Ekici, Arif B and Beckmann, Matthias W and dos Santos Silva, Isabel and Johnson, Nichola and Warren, Helen and Tomlinson, Ian and Kerin, Michael J and Miller, Nicola and Marme, Federick and Schneeweiss, Aneas and Sohn, Christof and Truong, Therese and Laurent-Puig, Pierre and Kerbrat, Pierre and Nordestgaard, Børge G and Nielsen, Sune F and Flyger, Henrik and Milne, Roger L and Perez, Jose Ignacio Arias and Menéndez, Primitiva and Müller, Heiko and Arndt, Volker and Stegmaier, Christa and Lichtner, Peter and Lochmann, Magdalena and Justenhoven, Christina and ... and KConFab Investigators and Gene ENvironm Interaction Breast and Familial Breast Canc Study FBCS and Australian Breast Canc Tissue Bank and kConFab Investigators and Familial Breast Cancer Study (FBCS) and Australian Breast Cancer Tissue Bank (ABCTB) Investigators and Gene ENvironmental Interaction and breast CAncer (GENICA) Network and The Gene ENvironmental Interaction and breast CAncer (GENICA) Network
Nature genetics, ISSN 1061-4036, 2013, Volume 45, Issue 4, pp. 392 - 398
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 25 - 35
Summary Background Palbociclib (PD-0332991) is an oral, small-molecule inhibitor of cyclin-dependent kinases (CDKs) 4 and 6 with preclinical evidence of... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | EXEMESTANE | ONCOLOGY | CELL-CYCLE | POSTMENOPAUSAL WOMEN | HER2 | PLUS | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Piperazines - administration & dosage | Triazoles - administration & dosage | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Receptors, Estrogen - analysis | Molecular Targeted Therapy | North America | Nitriles - administration & dosage | Breast Neoplasms - enzymology | Time Factors | Postmenopause | Female | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Republic of Korea | Aromatase Inhibitors - administration & dosage | Pyridines - administration & dosage | Drug Administration Schedule | Administration, Oral | Biomarkers, Tumor - analysis | Europe | Proportional Hazards Models | Cyclin-Dependent Kinase Inhibitor p16 - genetics | Treatment Outcome | Cyclin-Dependent Kinase 6 - metabolism | Cyclin-Dependent Kinase 4 - metabolism | Breast Neoplasms - drug therapy | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Breast Neoplasms - genetics | Cyclin D1 - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Intention to Treat Analysis | South Africa | Aged | Biomarkers, Tumor - genetics | Receptor, ErbB-2 - analysis | Antimitotic agents | Care and treatment | Oncology, Experimental | Estrogen | Breast cancer | Research | Antineoplastic agents | Phosphotransferases | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 4, pp. 425 - 439
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2011, Volume 365, Issue 14, pp. 1273 - 1283
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. 816 - 829
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 20, pp. 1925 - 1936
Journal Article
Cell, ISSN 0092-8674, 08/2015, Volume 162, Issue 5, pp. 974 - 986